期刊文献+

乙型肝炎病毒前S1抗原检测的临床意义 被引量:3

Clinical significance of hepatitis B virus Pre-S1 antigen
下载PDF
导出
摘要 目的研究乙型肝炎病毒(hepatitis B virus,HBV)前S1抗原(Pre-S1 antigen,Pre-S1Ag)检测的临床意义。方法用ELISA法对606例乙肝患者血清进行HBV“两对半”、Pre-S1Ag检测,其中对100例乙肝患者还检测了HBV-DNA。结果606例HBsAg(+)中,Pre-S1Ag阳性率为64.0%;168例HBsAg(+)、HBeAg(+)标本中,Pre-S1Ag阳性率为87.5%;438例HBsAg(+)、HBeAg(-)标本中,Pre-S1Ag阳性率为55.0%;在同时检测HBV-DNA与Pre-S1Ag的100例的各种感染模式中,Pre-S1Ag与HBV-DNA的阳性率也是比较吻合的。结论Pre-S1Ag可以反映HBV病毒感染与复制,是乙型肝炎早期诊断、疗效评估的可靠指标。 Objective To study the clinical significance of hepatiffs B virtu Pre-S1 antigen. Methods Pre-S1 antigen of 606 serums was detected by EHSA, and HBV-DNA of 100 serubs was tested by PCR at the sametime. Results The positive rate of Pre- S1 antigen was 64.0% in 606 cases of the HBsAg-positive group; The positive rate of Pre-S1 antigen was 87.5% in 168 cases of the HBsAg-positive and HBeAg-positive group; The positive rate of Pre-S1 antigen was 55.0% in 438 cases of the HBsAg-positive and HBeAg-negative group; The positive rate of Pre-S1 antigen and I-IBV-DNA was identical in 100 cases of different infection detected at the same. Conclusion HBV Pre-S1 antigen may reflect the replication and infection of hepatitis B virus, which can be used as a reliable marker of early diagnosis and the efficacy of therapy in hepatitis B,and have important significance in clinic.
出处 《中国实验诊断学》 2007年第5期641-644,共4页 Chinese Journal of Laboratory Diagnosis
关键词 乙型肝炎病毒 前S1抗原 HBV-DNA 病毒复制 Hepatitis B virus Pre-S1 antigen HBV-DNA virus replieation
  • 相关文献

参考文献12

二级参考文献47

  • 1汤钊猷.正确的诊断来自对临床资料全面和细致的分析[J].中国实验诊断学,1997,1(2):7-7. 被引量:3
  • 2Bhatnager PK, Papas E, Blum HE, etal. Immune response to synthetic peptic analogues of hepatitis B surface antigen specific for the "a" determinant[J]. Proc Natl Acad Sci USA, 1982,79:4400-4404.
  • 3Waters JA, O'Rourker SM, Richardson SC, etal. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine[J]. J Med Virol, 1987.21 : 155-160.
  • 4Neurath AR, Kent SBH, Parker K, et al. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus-neutralizing[J]. Vaccine, 1986,435-37.
  • 5Neurath AR, Kent SBH, Strick N, et al. Identification and chemical synthesis of a host cell binding site on hepatitis B virus[J]. Cell, 1986,46:429-436.
  • 6Guidotti LG, Ando MV, Hobbs T, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice[J]. Proc Natl Acad Sci USA, 1994,91:3764.
  • 7Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and interferon α/β downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways[J]. J Virol, 1994,68 : 1265.
  • 8Guidotti LG, Matzke B, Schaller H, et al. High level hepatitis B virus replication in transgenic mice[J]. J Virol, 1995,69:1265.
  • 9Gilles PN, Fey G, Chisari FV. Tumor necrosis factor α negatively regulates hepatitis B virus gene expression in transgenic mice[J]. J Virol,1992,66:3955.
  • 10Tlollais P, Charmay P, Vyas GN. Biology of the hepatitis Bvirus[J]. Science, 1981,213:408-441.

共引文献346

同被引文献23

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部